News

Scientific news
<p>The infective action is produced by the prion PrP106-126</p>
31 Mar 2008

Researchers at IRB Barcelona have demonstrated that the decrease in Dab1 protein expression caused by the infective action of prions also reduces the production of β-amyloid, a risk factor of Alzheimer’s disease.

Institutional news
10 Mar 2008

Epilepsy, cancer, diabetes and depression are just some examples of the severe diseases associated with mutations in these proteins.

Institutional news
<p>Antibiotic by Omnia</p>
5 Mar 2008

The biotech company Omnia Molecular shared by IRB Barcelona, opens its new facilities in the Barcelona Science Park.

Institutional news
19 Feb 2008

Otorgado por la revista Actualidad Económica y el diario Expansión

Scientific news
<p>Bacteria <i>M. Penetrans</i> has an extension in its enzime MetRS (in yellow) which makes it different from the rest of organisms. Stuying this enzime, the scientists discovered a new mechanism for genetic code translation</p>
14 Feb 2008

Researchers study the evolution of life by examining the translation of the genetic codes of several organisms, in order to discover differences between bacteria and humans that allow the design of new antibiotics

Scientific news
<p>Detail of a transcription factor bound to DNA.</p>
28 Jan 2008

The finding of researchers at the Barcelona Supercomputing Center (BSC) and the Institute for Research in Biomedicine (IRB Barcelona) has been possible thanks to the calculation capacity of the MareNostrum supercomputer.

Institutional news
25 Jan 2008

The European Research Council has awarded Eduard Batlle a Starting Grant for outstanding young researchers

Institutional news
<p>Jose M. Valpuesta, Mariano Barbacid, Carlos Martínez, Bernat Soria, Isidre Fainé, Joan Guinovart, Miguel Beato and Josep Francesc de Conrado.</p>
9 Jan 2008

IRB Barcelona will allocate 4.9 million Euros to attract young talented scientists over four years

Scientific news
20 Nov 2007

Researchers at IRB Barcelona report the first data on the functions of a new gene that is altered in diabetes, published in PLoS One.

Institutional news
14 Nov 2007

Biologist Marco Milán, Drosophila researcher at IRB Barcelona, has been awarded the EMBO Young Investigator Programme, given by the European Molecular Biology Organization (EMBO) to promising young European scientists for their early career excellence. The programme has been identifying and supporting on an annual basis some of the brightest young researchers in Europe since 2000.